Bile duct-bound growth of precursor cells of preneoplastic foci inducible in the initiation stage of rat chemical hepatocarcinogenesis by 2-acetylaminofluorene

Japanese Journal of Clinical Oncology

Volumn 38, Issue 9, 2008, Pages 604-610

  Satoh, Kimihiko ^a   Yamakawa, Daishi ^b   Sugio, Hideaki ^c   Kida, Kazuyuki ^a   Sato, Tatsusuke ^d   Hosoi, Kazuhiro ^a   Hayakari, Makoto ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Department of Pathologic Analysis ^*  (Japan)

Author keywords

glutamyltranspeptidase; 2 acetylaminofluorene; Glutathione S transferase; Hepatocarcinogenesis; Tumor marker enzyme

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; N (2 FLUORENYL)ACETAMIDE; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, RAT; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOCYTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER RESECTION; MALE; NONHUMAN; PRECANCER; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; STEM CELL; ANIMAL; BIOSYNTHESIS; ENZYMOLOGY; EVALUATION; LIVER TUMOR; PATHOLOGY;

2-ACETYLAMINOFLUORENE; ANIMALS; BILE DUCTS; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE S-TRANSFERASE PI; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR MARKERS, BIOLOGICAL;

EID: 52449102990     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn080     Document Type: Article

References (26)

1. Farber E, Cameron R. The sequential analysis of cancer development. Adv Cancer Res 1980;31:125-226.
2. Gibbs WW. Untangling the roots of cancer. Sci Am 2002;289:56-65.
3. Prehn RT. Cancers beget mutations versus mutations beget cancers. Cancer Res 1994;54:5296-300.
4. Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K. Purification, induction, and distribution of placental glutathione transferase: A new marker enzyme for preneoplastic cells in rat chemical hepatocarcinogenesis. Proc Natl Acad Sci USA 1985;82:3964-8.
5. Suguoka Y, Kano T, Okuda A, Sakai M, Kitagawa T, Muramatsu M. Cloning and the nucleotide sequence of rat glutathione S-transferase P cDNA. Nucleic Acids Res 1985;13:6049-57.
6. Moore MA, Nakagawa K, Satoh K, Ishikawa T, Sato K. Single GST-P positive liver cells-putative initiated hepatocytes. Carcinogenesis 1987;8:483-6.
7. Sato K. Glutathione transferases as markers of preneoplasia and neoplasia. Adv Cancer Res 1989;52:205-55.
8. Satoh K, Takahashi G, Miura T, Hayakari M, Hatayama I. Enzymatic detection of precursor cell populations of preneoplastic foci positive for γ-glutamyltranspeptidase in rat liver. Int J Cancer 2005;115:711-6.
9. Solt DB, Farber E. New principle for the analysis of chemical carcinogenesis. Nature 1976;263:702-3.
10. Rutenburg AM, Kim H, Fischbein JW, Hanker JS, Wasserkrug HL, Seligman AM. Histochemical and ultrastructural demonstration of γ-glutamyl transpeptidase activity. J Histochem Cytochem 1969;17:517-26.
11. Satoh K, Hatayama I, Tateoka N, Tamai K, Shimizu T, Tatematsu M, et al. Transient induction of single GST-P-positive hepatocytes by DEN. Carcinogenesis 1989;10:2107-11.
12. Campbell HA, Pitot HC, Potter VR, Laishes BA. Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver. Cancer Res 1982;42:465-72.
13. Miller EC, Miller JA. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 1981;47: 2327-45.
14. Levin W, Wood A, Chang R, Ryan D, Thomas P, Yagi H, et al. Oxidative metabolism of polycyclic aromatic hydrocarbons to ultimate carcinogens. Drug Metab Rev 1982;13:555-80.
15. Kitagawa T. Sequential phenotypic changes in hyperplastic areas during hepatocarcinogenesis in the rat. Cancer Res 1976;36:2534-9.
16. Grasl-Kraupp B, Luebeck G, Wagner A, Low-Baselli A, de Gunst M, Waldhor T, et al. Quantitative analysis of tumor initiation in rat liver: Role of cell replication and cell death (apoptosis). Carcinogenesis 2000;21:1411-21.
17. Levine WG. Biliary Excretion of Drugs and Other Xenobiotics. Annu Rev Pharmacol Toxicol 1978;18:81-96.
18. Irving CC, Wiseman R Jr, Hill JT. Biliary excretion of the O glucuronide of N-hydroxy-2-acetylamino-fluorene by the rat and rabbit. Cancer Res 1967;27:2309-17.
19. Fardel O, Payen L, Courtois A, Vernhet L, Lecureur V. Regulation of biliary drug efflux pump expression by hormones and xenobiotics. Toxicol 2001;167:37-46.
20. Farber E. Clonal adaptation during carcinogenesis. Biochem Pharmacol 1990;39:1837-46.
21. Farber E, Solt D, Cameron R, Laishes B, Ogawa K, Medline A. Newer insights into the pathogenesis of liver cancer. Am J Pathol 1977;89: 477-82.
22. Tsuda H, Lee G, Farber E. Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens. Cancer Res 1980;40:1157-64.
23. Pitot HC, Goodspeed D, Dunn T, Hendrich S, Maronpot RR, Moran S. Regulation of the expression of some genes for enzymes of glutathione metabolism in hepatotoxicity and hepatocarcinogenesis. Toxicol Appl Pharmacol 1989;97:23-34.
24. Satoh K, Hatayama I. Anomalous elevation of glutathione S transferase P-form (GST-P) in the elementary process of epigenetic initiation of chemical hepatocarcinogenesis in rats. Carcinogenesis 2002;23:1193-8.
25. Meister A, Tate SS. Glutathione and related gamma-glutamyl compounds: biosynthesis and utilization. Annu Rev Biochem 1976;45:559-604.
26. Goldberg DM. Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab Sci 1980;12:1-58.